ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $32 | +52.4% | 138,100 | +131.7% | 0.00% | – |
Q1 2023 | $21 | +133.3% | 59,600 | +111.3% | 0.00% | – |
Q4 2022 | $9 | -100.0% | 28,200 | -82.1% | 0.00% | – |
Q1 2022 | $235,000 | -35.4% | 157,450 | -6.2% | 0.00% | – |
Q4 2021 | $364,000 | +79.3% | 167,900 | +195.1% | 0.00% | – |
Q3 2021 | $203,000 | -53.2% | 56,900 | -24.7% | 0.00% | -100.0% |
Q2 2021 | $434,000 | -24.1% | 75,600 | -31.5% | 0.00% | 0.0% |
Q1 2021 | $572,000 | +300.0% | 110,300 | +47.7% | 0.00% | – |
Q2 2020 | $143,000 | -73.4% | 74,700 | -45.2% | 0.00% | – |
Q1 2019 | $538,000 | – | 136,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |